Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
* Rituxan - Generic: Rituximab | * Rituxan - Generic: Rituximab | ||
* Zevalin - Generic: Ibritumomab | * Zevalin - Generic: Ibritumomab | ||
| + | =====BCR-Abl Tyrosine Kinase Inhibitor===== | ||
| + | * [[Gleevec]] - Generic: Imatinib | ||
| + | * Tasigna - Generic: Nilotinib | ||
=====[[Epidermal Growth Factor Receptor]] Inhibitor===== | =====[[Epidermal Growth Factor Receptor]] Inhibitor===== | ||
* [[Herceptin]] - Generic: Trastuzumab | * [[Herceptin]] - Generic: Trastuzumab | ||
| Line 17: | Line 20: | ||
* Nolvadex - Generic: Tamoxifen | * Nolvadex - Generic: Tamoxifen | ||
=====Platelet-Derived Growth Factor Receptor Inhibitor===== | =====Platelet-Derived Growth Factor Receptor Inhibitor===== | ||
| - | * Gleevec - Generic: Imatinib | + | * [[Gleevec]] - Generic: Imatinib |
=====[[Vascular Endothelial Growth Factor]] Inhibitor===== | =====[[Vascular Endothelial Growth Factor]] Inhibitor===== | ||
* [[Avastin]] - Generic: Bevacizumab | * [[Avastin]] - Generic: Bevacizumab | ||
Revision as of 15:35, 10 December 2010
Anti-CD20 Monoclonal Antibody
BCR-Abl Tyrosine Kinase Inhibitor
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Antagonist
Platelet-Derived Growth Factor Receptor Inhibitor
Vascular Endothelial Growth Factor Inhibitor
Vascular Endothelial Growth Factor Receptor & KIT Inhibitor |
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
